Immunology and the menstrual cycle

Channing, 1980, Ovarian follicular and luteal physiology, Int Rev Physiol, 22, 117

Whitacre, 1999, A gender gap in autoimmunity, Science, 283, 1277, 10.1126/science.283.5406.1277

Miyaura, 2002, Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids, J Immunol, 168, 1087, 10.4049/jimmunol.168.3.1087

Mortola, 1998, Premenstrual syndrome—pathophysiologic considerations, N Engl J Med, 338, 256, 10.1056/NEJM199801223380409

Cunningham, 2011, Estrogen receptors in immunity and autoimmunity, Clin Rev Allergy Immunol, 40, 66, 10.1007/s12016-010-8203-5

Couse, 1997, Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse, Endocrinology, 138, 4613, 10.1210/en.138.11.4613

Hall, 1999, The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens, Endocrinology, 140, 5566, 10.1210/en.140.12.5566

Dosiou, 2008, Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone, J Endocrinol, 196, 67, 10.1677/JOE-07-0317

Szekeres-Bartho, 1990, Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody, Cell Immunol, 125, 273, 10.1016/0008-8749(90)90083-4

Tanriverdi, 2003, The hypothalamic–pituitary–gonadal axis: immune function and autoimmunity, J Endocrinol, 176, 293, 10.1677/joe.0.1760293

Heldring, 2007, Estrogen receptors: how do they signal and what are their targets, Physiol Rev, 87, 905, 10.1152/physrev.00026.2006

Scarpin, 2009, Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression, Nucl Recept Signal, 7, e009, 10.1621/nrs.07009

Gameiro, 2010, Menopause and aging: changes in the immune system—a review, Maturitas, 67, 316, 10.1016/j.maturitas.2010.08.003

Lee, 2010, Fluctuation of peripheral blood T, B, and NK cells during a menstrual cycle of normal healthy women, J Immunol, 185, 756, 10.4049/jimmunol.0904192

Lopez-Karpovitchs, 1993, Peripheral blood lymphocyte subsets and serum immunoglobulins in Sheehan's syndrome and in normal women during the menstrual cycle, Rev Invest Clin, 45, 247

Correale, 1998, Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects, J Immunol, 161, 3365, 10.4049/jimmunol.161.7.3365

Faas, 2000, The immune response during the luteal phase of the ovarian cycle: a Th2-type response?, Fertil Steril, 74, 1008, 10.1016/S0015-0282(00)01553-3

Campbell, 2011, Phenotypical and functional specialization of FOXP3+ regulatory T cells, Nat Rev Immunol, 11, 119, 10.1038/nri2916

Heikkinen, 2004, Phenotypic characterization of regulatory T cells in the human decidua, Clin Exp Immunol, 136, 373, 10.1111/j.1365-2249.2004.02441.x

Somerset, 2004, Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset, Immunology, 112, 38, 10.1111/j.1365-2567.2004.01869.x

Prieto, 2006, Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation, Immunology, 118, 58, 10.1111/j.1365-2567.2006.02339.x

Arruvito, 2007, Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction, J Immunol, 178, 2572, 10.4049/jimmunol.178.4.2572

Peeva, 2005, Tamoxifen blocks estrogen-induced B cell maturation but not survival, J Immunol, 175, 1415, 10.4049/jimmunol.175.3.1415

Auerbach, 2002, Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle, Fertil Steril, 78, 83, 10.1016/S0015-0282(02)03173-4

Franklin, 1999, Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones, J Reprod Immunol, 42, 93, 10.1016/S0165-0378(98)00086-2

Mathur, 1979, Cyclic variations in white cell subpopulations in the human menstrual cycle: correlations with progesterone and estradiol, Clin Immunol Immunopathol, 13, 246, 10.1016/0090-1229(79)90069-2

Northern, 1994, Cyclic changes in the concentrations of peripheral blood immune cells during the normal menstrual cycle, Proc Soc Exp Biol Med, 207, 81, 10.3181/00379727-207-43795

Brannstrom, 1999, Variations in peripheral blood levels of immunoreactive tumor necrosis factor alpha (TNFalpha) throughout the menstrual cycle and secretion of TNFalpha from the human corpus luteum, Eur J Obstet Gynecol Reprod Biol, 83, 213, 10.1016/S0301-2115(99)00003-2

Polan, 1988, Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity, Fertil Steril, 49, 964, 10.1016/S0015-0282(16)59945-2

Angstwurm, 1997, Cyclic plasma IL-6 levels during normal menstrual cycle, Cytokine, 9, 370, 10.1006/cyto.1996.0178

Konecna, 2000, Modulation of IL-6 production during the menstrual cycle in vivo and in vitro, Brain Behav Immun, 14, 49, 10.1006/brbi.1999.0570

Bouman, 2001, Cytokine production by natural killer lymphocytes in follicular and luteal phase of the ovarian cycle in humans, Am J Reprod Immunol, 45, 130, 10.1111/j.8755-8920.2001.450302.x

Yovel, 2001, The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells, Gynecol Oncol, 81, 254, 10.1006/gyno.2001.6153

Souza, 2001, Influence of menstrual cycle on NK activity, J Reprod Immunol, 50, 151, 10.1016/S0165-0378(00)00091-7

Sulke, 1985, Variation in natural killer activity in peripheral blood during the menstrual cycle, Br Med J (Clin Res Ed), 290, 884, 10.1136/bmj.290.6472.884

Case, 1998, Effects of the menstrual cycle on medical disorders, Arch Intern Med, 158, 1405, 10.1001/archinte.158.13.1405

Steinberg, 1985, Lupus disease activity associated with menstrual cycle, J Rheumatol, 12, 816

Colangelo, 2011, Self-reported flaring varies during the menstrual cycle in systemic lupus erythematosus compared with rheumatoid arthritis and fibromyalgia, Rheumatology (Oxford), 50, 703, 10.1093/rheumatology/keq360

Medeiros, 2009, Menstrual and hormonal alterations in juvenile systemic lupus erythematosus, Lupus, 18, 38, 10.1177/0961203308094652

Shabanova, 2008, Ovarian function and disease activity in patients with systemic lupus erythematosus, Clin Exp Rheumatol, 26, 436

Zorgdrager, 1997, Menstrually related worsening of symptoms in multiple sclerosis, J Neurol Sci, 149, 95, 10.1016/S0022-510X(97)05396-3

Zorgdrager, 2002, The premenstrual period and exacerbations in multiple sclerosis, Eur Neurol, 48, 204, 10.1159/000066166

Tomassini, 2005, Sex hormones modulate brain damage in multiple sclerosis: MRI evidence, J Neurol Neurosurg Psychiatry, 76, 272, 10.1136/jnnp.2003.033324

Pozzilli, 1999, MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns, Neurology, 53, 622, 10.1212/WNL.53.3.622

Bansil, 1999, Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis, Acta Neurol Scand, 99, 91, 10.1111/j.1600-0404.1999.tb00663.x

Tengstrand, 2004, The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years, J Rheumatol, 31, 214

Latman, 1983, Relation of menstrual cycle phase to symptoms of rheumatoid arthritis, Am J Med, 74, 957, 10.1016/0002-9343(83)90789-1

Rudge, 1983, Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis, Ann Rheum Dis, 42, 425, 10.1136/ard.42.4.425

McDonagh, 1993, Menstrual arthritis, Ann Rheum Dis, 52, 65, 10.1136/ard.52.1.65

Tam, 2011, The role of female hormones on lung function in chronic lung diseases, BMC Womens Health, 11, 24, 10.1186/1472-6874-11-24

Fasco, 2002, Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue, Mol Cell Endocrinol, 188, 125, 10.1016/S0303-7207(01)00750-X

Hanley, 1981, Asthma variation with menstruation, Br J Dis Chest, 75, 306, 10.1016/0007-0971(81)90010-3

Chandler, 1997, Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors, Pharmacotherapy, 17, 224, 10.1002/j.1875-9114.1997.tb03703.x

Gibbs, 1984, Premenstrual exacerbation of asthma, Thorax, 39, 833, 10.1136/thx.39.11.833

Eliasson, 1986, Morbidity in asthma in relation to the menstrual cycle, J Allergy Clin Immunol, 77, 87, 10.1016/0091-6749(86)90328-3

Skobeloff, 1996, The effect of the menstrual cycle on asthma presentations in the emergency department, Arch Intern Med, 156, 1837, 10.1001/archinte.1996.00440150091010

Zimmerman, 2000, Relation between phase of menstrual cycle and emergency department visits for acute asthma, Am J Respir Crit Care Med, 162, 512, 10.1164/ajrccm.162.2.9910105

Boggess, 1990, Influence of the menstrual cycle on systemic diseases, Obstet Gynecol Clin North Am, 17, 321, 10.1016/S0889-8545(21)00217-5

Schoene, 1981, Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women, J Appl Physiol, 50, 1300, 10.1152/jappl.1981.50.6.1300

Haggerty, 2003, The impact of estrogen and progesterone on asthma, Ann Allergy Asthma Immunol, 90, 284, 10.1016/S1081-1206(10)61794-2

Farha, 2009, Effects of the menstrual cycle on lung function variables in women with asthma, Am J Respir Crit Care Med, 180, 304, 10.1164/rccm.200904-0497OC

Pauli, 1989, Influence of the menstrual cycle on airway function in asthmatic and normal subjects, Am Rev Respir Dis, 140, 358, 10.1164/ajrccm/140.2.358

Hayashi, 2003, Less sensitivity for late airway inflammation in males than females in BALB/c mice, Scand J Immunol, 57, 562, 10.1046/j.1365-3083.2003.01269.x

Ligeiro de Oliveira, 2004, Regulation of allergic lung inflammation in rats: interaction between estradiol and corticosterone, Neuroimmunomodulation, 11, 20, 10.1159/000072965

Shames, 1998, Clinical differences among women with and without self-reported perimenstrual asthma, Ann Allergy Asthma Immunol, 81, 65, 10.1016/S1081-1206(10)63111-0

Letterie, 1994, Catamenial insulin reactions treated with a long-acting gonadotropin releasing hormone agonist, Arch Intern Med, 154, 1868, 10.1001/archinte.1994.00420160108015

Ovalle, 2008, Catamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literature, Am J Med Sci, 335, 298, 10.1097/MAJ.0b013e31815adec8

Walsh, 1977, Menstruation and control of diabetes, Br Med J, 2, 177, 10.1136/bmj.2.6080.177

Goldner, 2004, Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes, Diabetes Technol Ther, 6, 473, 10.1089/1520915041705875

Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 138, 1, 10.7326/0003-4819-138-1-200301070-00005

Jarrett, 1968, Changes in oral glucose tolerance during the menstrual cycle, Br Med J, 2, 528, 10.1136/bmj.2.5604.528

Brennan, 2009, Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women, Am J Physiol Gastrointest Liver Physiol, 297, G602, 10.1152/ajpgi.00051.2009

Wald, 1981, Gastrointestinal transit: the effect of the menstrual cycle, Gastroenterology, 80, 1497, 10.1016/0016-5085(81)90263-8

Cawood, 1993, Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control, Diabet Med, 10, 444, 10.1111/j.1464-5491.1993.tb00096.x

Trout, 2004, Insulin sensitivity and premenstrual syndrome, Curr Diab Rep, 4, 273, 10.1007/s11892-004-0079-4

Blum, 2005, Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women, J Clin Endocrinol Metab, 90, 3230, 10.1210/jc.2005-0231

Geer, 2009, Gender differences in insulin resistance, body composition, and energy balance, Gend Med, 6, 60, 10.1016/j.genm.2009.02.002

Tiittanen, 2006, Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro, Diabetes, 55, 3446, 10.2337/db06-0132

Strotmeyer, 2003, Menstrual cycle differences between women with type 1 diabetes and women without diabetes, Diabetes Care, 26, 1016, 10.2337/diacare.26.4.1016

Gaborit, 2010, Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts, J Mol Cell Cardiol, 49, 639, 10.1016/j.yjmcc.2010.06.005

Kuch, 2001, Determinants of short-period heart rate variability in the general population, Cardiology, 95, 131, 10.1159/000047359

Stramba-Badiale, 1995, Are gender differences in QTc present at birth? MISNES Investigators. Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome, Am J Cardiol, 75, 1277, 10.1016/S0002-9149(99)80781-4

Stramba-Badiale, 1997, Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings, Eur Heart J, 18, 1000, 10.1093/oxfordjournals.eurheartj.a015357

Makkar, 1993, Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs, JAMA, 270, 2590, 10.1001/jama.1993.03510210076031

Burke, 1997, Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults, Am J Cardiol, 79, 178, 10.1016/S0002-9149(96)00707-2

Rodriguez, 2001, Drug-induced QT prolongation in women during the menstrual cycle, JAMA, 285, 1322, 10.1001/jama.285.10.1322

Nakagawa, 2006, Influence of menstrual cycle on QT interval dynamics, Pacing Clin Electrophysiol, 29, 607, 10.1111/j.1540-8159.2006.00407.x

Jonsson, 2010, Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology, Pharmacol Ther, 127, 9, 10.1016/j.pharmthera.2010.04.002

Goldstein, 1988, Gender and the expression of schizophrenia, J Psychiatr Res, 22, 141, 10.1016/0022-3956(88)90078-7

Glick, 1980, A new drug treatment for premenstrual exacerbation of schizophrenia, Compr Psychiatry, 21, 281, 10.1016/0010-440X(80)90032-2

Huber, 2004, Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis, Acta Psychiatr Scand, 109, 269, 10.1046/j.1600-0447.2003.00251.x

Riecher-Rossler, 1994, Can estradiol modulate schizophrenic symptomatology?, Schizophr Bull, 20, 203, 10.1093/schbul/20.1.203

Gattaz, 1994, Influence of the menstrual cycle phase on the therapeutic response in schizophrenia, Biol Psychiatry, 36, 137, 10.1016/0006-3223(94)91195-9

Hafner, 1991, Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments, Eur Arch Psychiatry Clin Neurosci, 241, 65, 10.1007/BF02193758

Di Paolo, 1982, Effect of prolactin and estradiol on rat striatal dopamine receptors, Life Sci, 31, 2921, 10.1016/0024-3205(82)90684-1

Disshon, 1998, Inhibition of striatal dopamine transporter activity by 17beta-estradiol, Eur J Pharmacol, 345, 207, 10.1016/S0014-2999(98)00008-9

Hruska, 1986, Elevation of striatal dopamine receptors by estrogen: dose and time studies, J Neurochem, 47, 1908, 10.1111/j.1471-4159.1986.tb13106.x